Matters of legal in nature including licensing, intellectual property, and lawsuits.
MENLO PARK, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Phillips has decided to retire from his role as the company’s Senior Vice President of Research and Development as of April 1, 2020.Mr. Phillips has... Read more
Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation SANTA CLARA, California, February 06, 2020 Agilent Technologies Inc. (NYSE: A) today announced it has reached an agreement with Twist Bioscience under which Twist has agreed to pay Agilent a sum of $22.5 million to settle Agilent’s claims against Twist, as... Read more
First placebo-controlled trial to include adults with SMA demonstrates risdiplam improved or stabilised motor function Medically meaningful and statistically significant results in primary and key secondary endpoints Pivotal SUNFISH Part 2 study population represents broad, real-world spectrum of people living with SMA Basel, 06 February 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today presented... Read more
CONTACT: Tony Lupo, Neogen Senior Director of Technical Services517/372-9200; tlupo@neogen.com LANSING, Mich., Feb. 5, 2020 — Neogen announced today that its Laboratory Services Group in Lansing, Mich., has received ISO/IEC 17025:2017 accreditation from the American Association for Laboratory Accreditation (A2LA) — the highest recognized quality standard in the world for testing laboratories. Receiving the accreditation means that... Read more
Agilent Announces CrossLab Group Leadership Transition Mark Doak to Retire May 1, Padraig McDonnell to lead Agilent CrossLab Group SANTA CLARA, California , January 23, 2020 Agilent Technologies Inc. (NYSE: A) today announced that Mark Doak, Agilent senior vice president and president of the Agilent CrossLab Group, has decided to retire on May 1, 2020.... Read more
Risdiplam demonstrated statistically significant and medically meaningful motor milestone improvement in infants with Type 1 SMA No treatment related safety findings leading to withdrawal seen in any risdiplam trial to date Data will be shared with health authorities globally Basel, 23 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results... Read more
Agilent Wins Multiple Innovation Awards Leading science industry publications recognize Agilent’s advances in mass spectrometry SANTA CLARA, Calif. , January 22, 2020 Agilent Technologies Inc. (NYSE: A) today announced that both The Analytical Scientist and The Medicine Maker have honored the Agilent InfinityLab LC/MSD iQ system with 2019 Innovation Awards. The award-winning mass spectrometer, introduced... Read more
The two companies have previously joined forces to provide humanitarian assistance to communities in Africa and Asia following water-related natural disasters Expanding their commercial partnership will help Xylem to continue responding to water crises across the globe more efficiently MIAMI & RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 16, 2020– DHL Global Forwarding, the air and ocean freight... Read more
Advanced BioMatrix acquires HyStem® technology for R&D marketTechnology highly synergistic with existing Advanced BioMatrix productsAdvanced BioMatrix to fully manufacture and distribute the HyStem® kits California, USA – January 14, 2020 – Advanced BioMatrix has acquired the HyStem® line of products from Lineage Cell Therapeutics – previously BioTime/ESI Bio/Glycosan. HyStem® kits are based on innovative thiolated hyaluronic... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership announcements that further the company’s commitment to unlocking the power of the genome. Speaking today at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco,... Read more